Beta Bionics (BBNX) Return on Capital Employed (2025 - 2026)
Beta Bionics' (BBNX) quarterly Return on Capital Employed came in at 26.35% in Q1 2026, down 240.0% year-on-year from 18.82% in Q1 2025, and down 9.72% quarter-over-quarter from 24.02% in Q4 2025.
Beta Bionics (BBNX) Return on Capital Employed (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Return on Capital Employed across 2 years of filings, most recently posting 26.35% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 26.35%, down 240.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 26.35% (down 240.0% YoY), and the FY2025 annual result was 34.42%, up 721.0% from the prior year.
- Return on Capital Employed came in at 26.35% for Q1 2026 at Beta Bionics, down from 24.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 19.88% in Q2 2025 to a low of 26.35% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Beta Bionics | 617.66 Mn | 587.36 Mn | 16.44 Mn | -26.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.35% |
| Dec 31, 2025 | -24.02% |
| Sep 30, 2025 | -22.52% |
| Jun 30, 2025 | -19.88% |
| Mar 31, 2025 | -23.95% |